X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (329) 329
Patent (93) 93
Conference Proceeding (16) 16
Publication (14) 14
Magazine Article (10) 10
Book Review (5) 5
Dissertation (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (100) 100
animals (58) 58
humans (57) 57
mice (49) 49
proteomics (39) 39
physics (37) 37
male (36) 36
cardiac & cardiovascular systems (33) 33
cells, cultured (27) 27
measuring (27) 27
testing (27) 27
peripheral vascular disease (26) 26
proteins (26) 26
research (25) 25
analysis (23) 23
chemistry (23) 23
metallurgy (23) 23
atherosclerosis (21) 21
expression (20) 20
female (20) 20
measuring electric variables (19) 19
measuring magnetic variables (19) 19
proteomics - methods (19) 19
hematology (18) 18
mice, inbred c57bl (18) 18
electricity (17) 17
mass spectrometry (17) 17
oxidative stress (16) 16
activation (15) 15
extracellular matrix (15) 15
abridged index medicus (14) 14
apoptosis (14) 14
biochemical research methods (14) 14
biochemistry & molecular biology (14) 14
cardiovascular (14) 14
general devices for heat treatment of ferrous or non-ferrousmetals or alloys (14) 14
making metal malleable by decarburisation, tempering or othertreatments (14) 14
metallurgy of iron (14) 14
modifying the physical structure of ferrous metals (14) 14
aged (11) 11
blasting (11) 11
cell biology (11) 11
cells (11) 11
genetic aspects (11) 11
heating (11) 11
lighting (11) 11
mechanical engineering (11) 11
middle aged (11) 11
rats (11) 11
tandem mass spectrometry (11) 11
weapons (11) 11
cell line, tumor (10) 10
general tagging of cross-sectional technologies spanning over several sections of the ipc (10) 10
general tagging of new technological developments (10) 10
in-vivo (10) 10
inflammation (10) 10
mass-spectrometry (10) 10
metabolism (10) 10
microrna (10) 10
micrornas (10) 10
risk factors (10) 10
smooth-muscle-cells (10) 10
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (10) 10
technologies or applications for mitigation or adaptation againstclimate change (10) 10
cardiology and cardiovascular medicine (9) 9
gene expression (9) 9
inhibition (9) 9
medicine, research & experimental (9) 9
mice, knockout (9) 9
myocytes, smooth muscle - metabolism (9) 9
oncology (9) 9
performing operations (9) 9
pharmacology & pharmacy (9) 9
physiological aspects (9) 9
reduction of greenhouse gas [ghg] emissions, related to energygeneration, transmission or distribution (9) 9
signal transduction (9) 9
transporting (9) 9
adult (8) 8
conversion or distribution of electric power (8) 8
disease (8) 8
electrophoresis, gel, two-dimensional (8) 8
extracellular matrix proteins - metabolism (8) 8
fibrosis (8) 8
generation (8) 8
metabolomics (8) 8
multidisciplinary sciences (8) 8
myocardium - metabolism (8) 8
phosphorylation (8) 8
rna interference (8) 8
statistical-model (8) 8
amino acid sequence (7) 7
apoptosis - drug effects (7) 7
biomarkers - metabolism (7) 7
calculating (7) 7
cancer (7) 7
cardiovascular disease (7) 7
cardiovascular diseases (7) 7
care and treatment (7) 7
cell proliferation (7) 7
computing (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 7, pp. 789 - 800
Abstract Background Routine apolipoprotein (apo) measurements for cardiovascular disease (CVD) are restricted to apoA-I and apoB. Here, the authors measured an... 
Cardiovascular | Internal Medicine | mass spectrometry | triglycerides | proteomics | lipidomics | CARDIAC & CARDIOVASCULAR SYSTEMS | RISK | OF-FUNCTION MUTATIONS | REMNANT CHOLESTEROL | METABOLISM | LDL | DISEASE | C-III | SECRETION | PLASMA TRIGLYCERIDES | Apolipoprotein C-III - antagonists & inhibitors | Prospective Studies | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Apolipoproteins - blood | Incidence | Lipoproteins, VLDL - blood | Mass Spectrometry | Cardiovascular Diseases - blood | Cardiovascular Diseases - epidemiology | Female | Aged | Medical colleges | Research institutes | Blood lipids | Apolipoproteins | Low density lipoproteins | Analysis | Mass spectrometry | Heart attack | Blood proteins | Studies | Lipids | Low density lipoprotein | Statins | Index Medicus | Abridged Index Medicus | HDL-C, high-density lipoprotein cholesterol | MS, mass spectrometry | PC, phosphatidylcholine | LDL-C, low-density lipoprotein cholesterol | CE, cholesterol ester | CVD, cardiovascular disease | DAG, diacylglycerol | VLDL, very-low-density lipoprotein | TAG, triacylglycerol | TG, triglyceride | TRL, triglyceride-rich lipoprotein | apo, apolipoprotein | FCS, familial chylomicronemia syndrome | MRM, multiple reaction monitoring | HDL, high-density lipoprotein | LDL, low-density lipoprotein | Original Investigation
Journal Article
Journal Article
Nature Cell Biology, ISSN 1465-7392, 2012, Volume 14, Issue 3, pp. 249 - 256
The shear-responsive transcription factor Kruppel-like factor 2 (KLF2) is a critical regulator of endothelial gene expression patterns induced by... 
REGULATOR | MECHANISM | INTEGRATION | PHENOTYPE | MICRORNAS | MICROPARTICLES | TRANSCRIPTION FACTOR | EXPRESSION | KLF2 | FLOW | CELL BIOLOGY | Exosomes - metabolism | Apolipoproteins E - deficiency | Human Umbilical Vein Endothelial Cells - metabolism | Lovastatin - pharmacology | Atherosclerosis - genetics | Coculture Techniques | Humans | Endothelial Cells - transplantation | Stress, Mechanical | MicroRNAs - metabolism | Lovastatin - analogs & derivatives | Aorta - metabolism | Transfection | Kruppel-Like Transcription Factors - metabolism | Human Umbilical Vein Endothelial Cells - cytology | Myocytes, Smooth Muscle - cytology | Myocytes, Smooth Muscle - metabolism | Exosomes - ultrastructure | Atherosclerosis - pathology | Exosomes - transplantation | Endothelial Cells - metabolism | Cells, Cultured | Signal Transduction - genetics | Microscopy, Electron | Reverse Transcriptase Polymerase Chain Reaction | Atherosclerosis - metabolism | Mice, Knockout | Aorta - pathology | Gene Expression Regulation - drug effects | Microscopy, Confocal | Animals | Endothelial Cells - cytology | Apolipoproteins E - genetics | Mice | MicroRNAs - genetics | Kruppel-Like Transcription Factors - genetics | Transcription factors | MicroRNA | Atherosclerosis | Physiological aspects | Genetic aspects | Research | Gene expression | Risk factors | Index Medicus
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2008, Volume 51, Issue 5, pp. 585 - 594
Journal Article
Circulation, ISSN 0009-7322, 02/2012, Volume 125, Issue 6, pp. 789 - 802
Journal Article
Diabetes, ISSN 0012-1797, 02/2017, Volume 66, Issue 2, pp. 347 - 357
MicroRNA-122 (miR-122) is abundant in the liver and involved in lipid homeostasis, but its relevance to the long-term risk of developing metabolic disorders is... 
MIR-122 | LIPID-METABOLISM | PLASMA | INSULIN-RESISTANCE | IN-VIVO | ENDOCRINOLOGY & METABOLISM | CARDIOVASCULAR-DISEASE | DENSITY-LIPOPROTEINS | OUTCOMES | PRIMATES | BRUNECK | Multivariate Analysis | Prevalence | Prospective Studies | Atorvastatin Calcium - pharmacology | Humans | Middle Aged | Glycoproteins - metabolism | Male | Metabolic Syndrome - metabolism | MicroRNAs - metabolism | Diabetes Mellitus, Type 2 - metabolism | Hepatocytes - metabolism | Serum Albumin, Human | Diabetes Mellitus, Type 2 - epidemiology | Incidence | Oligonucleotides - pharmacology | Mass Spectrometry | Adult | Female | Real-Time Polymerase Chain Reaction | Atorvastatin Calcium - therapeutic use | Hepatocytes - drug effects | Metabolic Syndrome - epidemiology | Dyslipidemias - drug therapy | Insulin Resistance | Lipid Metabolism | Reverse Transcriptase Polymerase Chain Reaction | Obesity - metabolism | Blotting, Northern | Animals | Carrier Proteins - metabolism | Complement Factor H - metabolism | Dyslipidemias - epidemiology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Lipoproteins, VLDL - metabolism | Obesity - epidemiology | MicroRNAs - drug effects | Dyslipidemias - metabolism | Aged | Mice | Serum Albumin - metabolism | Type 2 diabetes | MicroRNA | Analysis | Research | Metabolic syndrome X | Risk factors | Public health | Proteins | Proteomics | Lipids | Insulin resistance | Diabetes | Mass spectrometry | Fatty acids | Index Medicus | Abridged Index Medicus | Metabolism
Journal Article
Journal of the American Chemical Society, ISSN 0002-7863, 08/2013, Volume 135, Issue 31, pp. 11425 - 11428
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2014, Volume 9, Issue 4, p. e94777
Biomass conversion factors (BCFs, defined as the ratios of tree components (i.e. stem, branch, foliage and root), as well as aboveground and whole biomass of... 
Forests | Parameter estimation | Growth rate | Laboratories | Soil fertility | Climatic data | Biomass | Datasets | Leaves | Prediction models | Forest biomass | Foliage | Physiology | Qualitative analysis | Trees | Annual precipitation | Rainfall | Ecology | Environmental factors | Estimates | Carbon | Conversion | Carbon sequestration | Studies | Soils | Hydrologic data | Vegetation | Environmental accounting | Variation
Journal Article
EMBO Molecular Medicine, ISSN 1757-4676, 09/2014, Volume 6, Issue 9, pp. 1133 - 1141
Journal Article
Arteriosclerosis, Thrombosis, and Vascular Biology, ISSN 1079-5642, 09/2019, Volume 39, Issue 9, pp. 1859 - 1873
OBJECTIVE:Marfan syndrome (MFS) is caused by mutations in FBN1 (fibrillin-1), an extracellular matrix (ECM) component, which is modified post-translationally... 
Journal Article